Renal cell carcinoma (RCC) accounts for a significant portion of new cancer diagnoses, with a subset presenting with tumor thrombus in the inferior vena cava (IVC), complicating treatment and prognosis. Despite surgical intervention being the standard for non-metastatic RCC with IVC thrombus, the role of minimally invasive techniques and systemic therapies remains underexplored. Here, we systematically review the histopathologic features and oncological outcomes of non-metastatic RCC with IVC thrombus, analyzing data from 19 studies. Our findings indicate a high prevalence of clear cell histology and significant variability in survival outcomes based on histological subtypes and thrombus extent. The study underscores the potential of tailored therapeutic strategies, including neoadjuvant and adjuvant therapies, to improve patient outcomes. These insights contribute to refining treatment protocols and highlight the need for further research into personalized treatment approaches for RCC with IVC involvement.

Histopathology and outcomes of non-metastatic renal cell carcinoma with inferior vena cava tumor thrombus: systematic review and meta-analysis

Lasorsa, Francesco;Rutigliano, Monica;Ditonno, Pasquale;Lucarelli, Giuseppe
2025-01-01

Abstract

Renal cell carcinoma (RCC) accounts for a significant portion of new cancer diagnoses, with a subset presenting with tumor thrombus in the inferior vena cava (IVC), complicating treatment and prognosis. Despite surgical intervention being the standard for non-metastatic RCC with IVC thrombus, the role of minimally invasive techniques and systemic therapies remains underexplored. Here, we systematically review the histopathologic features and oncological outcomes of non-metastatic RCC with IVC thrombus, analyzing data from 19 studies. Our findings indicate a high prevalence of clear cell histology and significant variability in survival outcomes based on histological subtypes and thrombus extent. The study underscores the potential of tailored therapeutic strategies, including neoadjuvant and adjuvant therapies, to improve patient outcomes. These insights contribute to refining treatment protocols and highlight the need for further research into personalized treatment approaches for RCC with IVC involvement.
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11586/599157
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 7
  • Scopus 12
  • ???jsp.display-item.citation.isi??? ND
social impact